|
SEED Grant |
Robert Oshima |
Trophoblast differentiation of human ES cells. |
$696,354 |
|
Shared Labs |
Evan Snyder |
Collaborative Laboratory for Human Embryonic Stem Cell Research at Sanford-Burnham Medical Research Institute |
$1,805,884 |
|
Disease Team Planning |
Mark Mercola |
"Stem Cell Therapies for Heart Failure" |
$44,450 |
|
SEED Grant |
Hudson Freeze |
Role of Glycans in Human Embryonic Stem Cell Conversion to Neural Precursor Cells |
$708,000 |
|
Research Leadership |
Robert Wechsler-Reya |
The role of neural stem cells in cerebellar development, regeneration and tumorigenesis |
$5,226,049 |
|
Shared Labs |
Jeanne Loring |
Collaborative Laboratory for Human Embryonic Stem Cell Research at Sanford-Burnham Medical Research Institute |
$1,361,825 |
|
SEED Grant |
Gregg Duester |
Retinoic Acid-FGF Antagonism during Motor Neuron Differentiation of Human ES Cells |
$695,229 |
|
Research Training II |
Alessandra Sacco |
Type III CIRM Stem Cell Research Training Program |
$2,781,376 |
|
Inception - Discovery Stage Research Projects |
Alessandra Sacco |
Generation of expandable, self-renewing muscle stem cells for Duchenne Muscular Dystrophy |
$252,000 |
|
SEED Grant |
Zhuohua Zhang |
Modeling Parkinson's Disease Using Human Embryonic Stem Cells |
$701,060 |
|
Disease Team Therapy Planning I |
Stuart Lipton |
hESC-derived NPCs Programmed with MEF2C for Cell Transplantation in Parkinson’s Disease |
$96,448 |
|
Therapeutic Translational Research Projects |
Evan Snyder |
Human Neural Stem Cells (hNSCs) for neuroprotection in perinatal hypoxic-ischemic brain injury (HII)-Pre-IND-enabling Studies |
$4,963,684 |
|
Basic Biology II |
Huei-sheng Chen |
Endothelial cells and ion channel maturation of human stem cell-derived cardiomyocytes |
$1,587,610 |
|
SEED Grant |
Ziwei Huang |
New Chemokine-Derived Therapeutics Targeting Stem Cell Migration |
$708,000 |
|
Disease Team Therapy Planning I |
Marcel Daadi |
Neural Stem Cell-Based Therapy For Parkinson’s Disease |
$63,952 |
|
Discovery Research Projects |
Evan Snyder |
Using hiPSC-derived lung organoids, a clinically-relevant system, to validate & winnow a list of approved drugs that inhibit SARS-CoV-2 cytopathy |
$228,229 |
|
New Cell Lines |
Zhuohua Zhang |
Derivation of Parkinson's Disease Coded-Stem Cells (PD-SCs) |
$1,556,448 |
|
Comprehensive Grant |
Stuart Lipton |
MEF2C-Directed Neurogenesis From Human Embryonic Stem Cells |
$2,832,000 |
|
Training Grant I-2 |
Mark Mercola |
Burnham Institute CIRM Stem Cell Training Grant (Type II) |
$1,061,865 |
|
Research Training Grant |
Evan Snyder |
A Multidisciplinary Stem Cell Training Program at Sanford Burnham Prebys Institute, A Critical Component of the La Jolla Mesa Educational Network |
$4,915,671 |
|
SEED Grant |
Huei-sheng Chen |
Development of Neuro-Coupled Human Embryonic Stem Cell-Derived Cardiac Pacemaker Cells. |
$695,680 |
|
Comprehensive Grant |
Mark Mercola |
Chemical Genetic Approach to Production of hESC-derived Cardiomyocytes |
$2,832,000 |
|
Basic Biology IV |
Huei-sheng Chen |
Studying Arrhythmogenic Right Ventricular Dysplasia with patient-specific iPS cells |
$1,579,250 |
|
SPARK |
Paula Checchi |
Stem Cells & STEM Education - a Summer Internship Program for California High School Students |
$509,000 |
|
SEED Grant |
Alexey Terskikh |
Analysis of Candidate Neural Crest Cells Derived from Human ES Cells |
$703,684 |
|
Early Translational I |
Evan Snyder |
Developmental Candidates for Cell-Based Therapies for Parkinson's Disease (PD) |
$5,190,752 |
|
Early Translational IV |
Stuart Lipton |
Programming Human ESC-derived Neural Stem Cells with MEF2C for Transplantation in Stroke |
$1,020,815 |
